Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.
Constantine J KarvellasJaime L SpeiserMélanie TremblayWilliam M LeeChristopher F Rosenull nullPublished in: Hepatology (Baltimore, Md.) (2017)
In patients with APAP-ALF, FABP1 may have good potential to discriminate survivors from nonsurvivors and may improve models currently used in clinical practice; validation of FABP1 as a clinical prediction tool in APAP-ALF warrants further investigation. (Hepatology 2017;65:938-949).